7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

NLS Pharmaceutics Ltd.
(NASDAQ:NLSP) 

NLSP stock logo

NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of drug therapies to treat rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, a...

Founded: 2015
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
NLS Pharmaceutics . Days Payable Outstanding ttm (DPO)
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 014.2328.4642.6956.9271.1485.3799.6Thousand
NLS Pharmaceutics . Days Inventory Outstanding ttm (DIO)
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -2.060.663.376.088.811.5114.2316.94Thousand
NLS Pharmaceutics . Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -1.27-1.09-0.91-0.72-0.54-0.36-0.180
NLS Pharmaceutics . Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -1.27-1.09-0.91-0.73-0.54-0.36-0.180
NLS Pharmaceutics . Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.070.150.220.290.370.440.51
NLS Pharmaceutics . (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -2.72-2.33-1.94-1.55-1.17-0.78-0.390
NLS Pharmaceutics . P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -3.571.666.8812.1117.3322.5627.7933.01
No extra charts and metrics for this ticker.